Global Bioprocessing Supplies Market Size Forecast To Cross $12.35 Billion By 2030

The Business Research Company

The Business Research Company's Bioprocessing Supplies Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, September 5, 2026 /EINPresswire.com/ -- "The bioprocessing supplies market plays a crucial role in the production of biologics and other advanced therapies, supporting the pharmaceutical and biotechnology sectors significantly. As the demand for sophisticated biologic treatments and personalized medicines rises, this market is witnessing consistent growth driven by innovation and expanding global healthcare needs. Let’s explore the current market size, key growth factors, leading regions, and emerging trends shaping the industry.

Current Market Size and Projected Growth in Bioprocessing Supplies
The bioprocessing supplies market has shown steady expansion in recent years. It is set to increase from $10.31 billion in 2025 to $10.73 billion in 2026, representing a compound annual growth rate (CAGR) of 4.0%. This growth during the historical period has been fueled by the rise in biologics and vaccine manufacturing, both of which require high-purity consumables. Additionally, the growing adoption of disposable bioprocess systems, the outsourcing of pharmaceutical production to contract manufacturing organizations, a strong emphasis on contamination-free environments, and the establishment of standardized good manufacturing practices (GMP) for bioprocess materials have all contributed to this upward trend.

Download a free sample of the bioprocessing supplies market report:
https://thebusinessresearchcompany.com/sample_request?id=59777593&type=smp&name=Bioprocessing%20Supplies%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR

Looking ahead, the market is anticipated to maintain a steady pace, reaching $12.35 billion by 2030 with a CAGR of 3.6%. Factors driving this forecast include escalating demand for personalized medicine and sophisticated biologics, expansion of cell and gene therapy manufacturing pipelines that require specialized consumables, and increased investments in localized biomanufacturing supply chains. Other notable contributors are the growing interest in sustainable, recyclable bioprocess materials, along with a rising global need for scalable single-use technologies in industrial bioproduction. Emerging trends during this period highlight the standardization of single-use consumables to ensure quality consistency, a surge in demand for pre-sterilized and gamma-irradiated supplies, the development of cold chain-compatible materials for temperature-sensitive biologics, increased adoption of regulatory-compliant disposable packaging to prevent contamination, and efforts to localize raw material sourcing to minimize supply disruptions.

Understanding Bioprocessing Supplies and Their Role in Biomanufacturing
Bioprocessing supplies consist of the essential materials and consumables used within controlled environments to facilitate biological production processes. These components are critical to preserving process integrity, sterility, and consistency throughout biomanufacturing operations. By ensuring reproducibility and robust quality control, bioprocessing supplies support the reliable manufacture of biologic drugs and related products.

View the full bioprocessing supplies market report:
https://www.thebusinessresearchcompany.com/report/bioprocessing-supplies-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Sep_PR

Rising Demand for Biologics and Biosimilars as a Growth Catalyst
One of the primary forces propelling the bioprocessing supplies market is the increasing demand for biologics and biosimilars. Biologics are complex medications derived from living organisms, while biosimilars are nearly identical versions that become available after original patents expire. The need for these advanced therapies is driven by the growing prevalence of chronic and complex diseases, which often require more targeted and effective treatments than traditional drugs can offer. Bioprocessing supplies facilitate the sterile, scalable, and tightly controlled manufacturing processes necessary to produce these intricate biologic molecules with consistent safety and quality. For example, in January 2023, Cardinal Health Inc. reported that by January 2022, the FDA had approved 33 biosimilar products in the US, with 21 commercially available. This number rose to 40 approved biosimilars and 25 on the market by 2023. Such growth in biosimilars clearly supports the expanding demand for bioprocessing consumables.

Regional Insights Highlight North America’s Market Leadership and Asia-Pacific’s Rapid Expansion
In 2025, North America held the largest share of the global bioprocessing supplies market, reflecting its well-established pharmaceutical and biotechnology industries. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market in the coming years. This growth can be attributed to increasing investments in biomanufacturing infrastructure, rising healthcare expenditures, and expanding cell and gene therapy pipelines in the region. The market report covers a broad geographical scope, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X